Precision
biotransformation is an envisioned strategy offering
detailed insights into biotransformation pathways in real environmental
settings using experimentally guided high-accuracy quantum chemistry.
Emerging pollutants, whose metabolites are easily overlooked but may
cause idiosyncratic toxicity, are important targets of such a strategy.
We demonstrate here that complex metabolic reactions of tris(1,3-dichloro-2-propyl)
phosphate (TDCIPP) catalyzed by human CYP450 enzymes can be mapped
via a three-step synergy strategy: (i) screening the possible metabolites
via high-throughout (moderate-accuracy) computations; (ii) analyzing
the proposed metabolites in vitro by human liver
microsomes and recombinant human CYP450 enzymes; and (iii) rationalizing
the experimental data via precise mechanisms using high-level targeted
computations. Through the bilateral dialogues from qualitative to
semi-quantitative to quantitative levels, we show how TDCIPP metabolism
especially by CYP3A4 generates bis(1,3-dichloro-2-propyl) phosphate
(BDCIPP) as an O-dealkylation metabolite and bis(1,3-dichloro-2-propyl)
3-chloro-1-hydroxy-2-propyl phosphate (alcoholβ‑dehalogen) as a dehalogenation/reduction metabolite via the initial rate-determining
H-abstraction from αC- and βC-positions. The relative
yield ratio [dehalogenation/reduction]/[O-dealkylation] is derived
from the relative barriers of H-abstraction at the βC- and αC-positions
by CYP3A4, estimated as 0.002 to 0.23, viz., an in vitro measured ratio of 0.04. Importantly, alcoholβ‑dehalogen formation points to a new mechanism involving successive oxidation
and reduction functions of CYP450, with its precursor aldehydeβ‑dehalogen being a key intermediate detected
by trapping assays and rationalized by computations. We conclude that
the proposed three-step synergy strategy may meet the increasing challenge
of elucidating biotransformation mechanisms of substantial synthesized
organic compounds in the future.
Biotransformation, especially by
human CYP450 enzymes, plays a
crucial role in regulating the toxicity of organic compounds in organisms,
but is poorly understood for most emerging pollutants, as their numerous
“unusual” biotransformation reactions cannot retrieve
examples from the textbooks. Therefore, in order to predict the unknown
metabolites with altering toxicological profiles, there is a realistic
need to develop efficient methods to reveal the “unusual”
metabolic mechanism of emerging pollutants. Combining experimental
work with computational predictions has been widely accepted as an
effective approach in studying complex metabolic reactions; however,
the full quantum chemical computations may not be easily accessible
for most environmentalists. Alternatively, this work practiced using
the concepts from physical organic chemistry for studying the interrelationships
between structure and reactivity of organic molecules, to reveal the
“unusual” metabolic mechanism of synthetic phenolic
antioxidants catalyzed by CYP450, for which the simple pencil-and-paper
and property-computation methods based on physical organic chemistry
were performed. The phenol-coupling product of butylated hydroxyanisole
(BHA) (based on spin aromatic delocalization) and ipso-addition quinol metabolite of butylated hydroxytoluene (BHT) (based
on hyperconjugative effect) were predicted as two “unusual”
metabolites, which were further confirmed by our in vitro analysis. We hope this easily handled approach will promote environmentalists
to attach importance to physical organic chemistry, with an eye to
being able to use the knowledge gained to efficiently predict the
fates of substantial unknown synthesized organic compounds in the
future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.